Interferon alfa-2b Interactions
There are 236 drugs known to interact with interferon alfa-2b, along with 11 disease interactions. Of the total drug interactions, 40 are major, 192 are moderate, and 4 are minor.
- View all 236 medications that may interact with interferon alfa-2b
- View interferon alfa-2b disease interactions (11)
Most frequently checked interactions
View interaction reports for interferon alfa-2b and the medicines listed below.
- Activated Charcoal (charcoal)
- Activated Charcoal (charcoal)
- Amoxil (amoxicillin)
- Amoxil (amoxicillin)
- Diltiazem Hydrochloride SR (diltiazem)
- Diltiazem Hydrochloride SR (diltiazem)
- Iodides (sodium iodide)
- Iodides (sodium iodide)
- Lithium Carbonate ER (lithium)
- Lithium Carbonate ER (lithium)
- Lyrica (pregabalin)
- Lyrica (pregabalin)
- Metoprolol Tartrate (metoprolol)
- Metoprolol Tartrate (metoprolol)
- MetroGel (metronidazole topical)
- MetroGel (metronidazole topical)
- Mycostatin (nystatin)
- Mycostatin (nystatin)
- OxyContin (oxycodone)
- OxyContin (oxycodone)
- Paracetamol (acetaminophen)
- Paracetamol (acetaminophen)
- Penicillin G Procaine (procaine penicillin)
- Penicillin G Procaine (procaine penicillin)
- Valproate Sodium (valproic acid)
- Valproate Sodium (valproic acid)
- Xanax (alprazolam)
- Xanax (alprazolam)
- Zofran (ondansetron)
- Zofran (ondansetron)
Interferon alfa-2b disease interactions
There are 11 disease interactions with interferon alfa-2b which include:
- renal dysfunction
- autoimmune diseases
- hepatic dysfunction
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- colitis
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
Report options
QR code containing a link to this page
More about interferon alfa-2b
- interferon alfa-2b consumer information
- Compare alternatives
- Reviews (9)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.